 |
Dyspnea: A Merck Manual of Patient Symptoms podcast
Dyspnea is unpleasant or uncomfortable breathing. It is experienced and described differently by patients depending on the cause.
Pathophysiology
Although dyspnea is a relatively common problem, the pathophysiology of the uncomfortable sensation of breathing is poorly understood. Unlike those for other types of noxious stimuli, there are no specialized dyspnea receptors, although recent MRI studies have identified a few specific areas in the midbrain that may mediate perception of dyspnea.
The experience of dyspnea likely results from a complex interaction between chemoreceptor stimulation, mechanical abnormalities in breathing, and the perception of those abnormalities by the CNS. Some authors have described the imbalance between neurologic stimulation and mechanical changes in the lungs and chest wall as neuromechanical uncoupling.
Etiology
Dyspnea has many pulmonary, cardiac, and other causes, which vary by acuity of onset (see Table 2: Symptoms of Pulmonary Disorders: Some Causes of Acute* Dyspnea , Table 3: Symptoms of Pulmonary Disorders: Some Causes of Subacute* Dyspnea , and Table 4: Symptoms of Pulmonary Disorders: Some Causes of Chronic* Dyspnea ).
The most common causes include
The most common cause of dyspnea in patients with chronic pulmonary or cardiac disorders is
However, such patients may also acutely develop another condition (eg, a patient with long-standing asthma may have an MI, a patient with chronic heart failure may develop pneumonia).
|
Table 2
|
PrintOpen table in new window  |
 |  |  |
| Some Causes of Acute* Dyspnea |
|
Cause
|
Suggestive Findings
|
Diagnostic Approach†
|
|
Pulmonary causes
|
|
Pneumothorax
|
Abrupt onset of sharp chest pain, tachypnea, diminished breath sounds, and hyperresonance to percussion
May follow injury or occur spontaneously (especially in tall, thin patients and in patients with COPD)
|
Chest x-ray
|
|
Pulmonary embolism
|
Abrupt onset of sharp chest pain, tachypnea, and tachycardia
Often risk factors for pulmonary embolism (eg, cancer, immobilization, DVT, pregnancy, use of oral contraceptives or other estrogen-containing drugs, recent surgery or hospitalization, family history)
|
CT angiography or V/Q scanning
Doppler or duplex studies of extremities showing findings of DVT
|
|
Asthma, bronchospasm, or reactive airway disease
|
Wheezing and poor air exchange that arise spontaneously or after exposure to specific stimuli (eg, allergen, URI, cold, exercise)
Possibly pulsus paradoxus
Often a preexisting history of reactive airway disease
|
Clinical evaluation
Sometimes pulmonary function testing or bedside peak flow measurement
|
|
Foreign body inhalation
|
Sudden onset of cough or stridor in a patient (typically an infant or young child) without URI or constitutional symptoms
|
Inspiratory and expiratory chest x-rays
Sometimes bronchoscopy
|
|
Toxin-induced airway damage (eg, due to inhalation of chlorine or hydrogen sulfide)
|
Sudden onset after occupational exposure or inappropriate use of cleaning agents
|
Inhalation usually obvious by history
Chest x-ray
Sometimes ABGs and observation to determine severity
|
|
Cardiac causes
|
|
Acute myocardial ischemia or infarction
|
Substernal chest pressure or pain that may or may not radiate to the arm or jaw, particularly in patients with risk factors for CAD
|
ECG
Cardiac enzyme testing
|
|
Papillary muscle dysfunction or rupture
|
Sudden onset of chest pain, new or loud holosystolic murmur, and signs of heart failure, particularly in patients with recent MI
|
Auscultation
Echocardiography
|
|
Heart failure
|
Crackles, S3 gallop, and signs of central or peripheral volume overload (eg, elevated neck veins, peripheral edema)
Dyspnea while lying flat (orthopnea) or appearing 1–2 h after falling asleep (paroxysmal nocturnal dyspnea)
|
Auscultation
Chest x-ray
BNP measurement
Echocardiography
|
|
Other causes
|
|
Diaphragmatic paralysis
|
Sudden onset after trauma affecting the phrenic nerve
Frequent orthopnea
|
Chest x-ray
Fluoroscopic sniff test
|
|
Anxiety disorder causing hyperventilation
|
Situational dyspnea often accompanied by psychomotor agitation and paresthesias in the fingers or around the mouth
Normal examination findings and pulse oximetry measurements
|
Clinical evaluation
Diagnosis of exclusion
|
|
*Acute dyspnea occurs within minutes of triggering event.
|
|
†Most patients should have pulse oximetry and, unless symptoms are clearly a mild exacerbation of known chronic disease, chest x-ray.
|
|
BNP = brain (B-type) natriuretic peptide; DVT = deep venous thrombosis; S3
= 3rd heart sound; V/Q = ventilation/perfusion.
|
|
|
Table 3
|
PrintOpen table in new window  |
 |  |  |
| Some Causes of Subacute* Dyspnea |
|
Cause
|
Suggestive Findings
|
Diagnostic Approach†
|
|
Pulmonary causes
|
|
Pneumonia
|
Fever, productive cough, dyspnea, sometimes pleuritic chest pain
Focal lung findings, including crackles, decreased breath sounds, and egophony
|
Chest x-ray
Sometimes blood and sputum cultures
WBC count
|
|
COPD exacerbation
|
Cough, productive or nonproductive
Poor air movement
Accessory muscle use or pursed lip breathing
|
Clinical evaluation
Sometimes chest x-ray and ABGs
|
|
Cardiac causes
|
|
Angina or CAD
|
Substernal chest pressure with or without radiation to the arm or jaw, often provoked by physical exertion, particularly in patients with risk factors for CAD
|
ECG
Cardiac stress testing
Cardiac catheterization
|
|
Pericardial effusion or tamponade
|
Muffled heart sounds or enlarged cardiac silhouette in patients with risk factors for pericardial effusion (eg, cancer, pericarditis, SLE)
Possibly pulsus paradoxus
|
Echocardiography
|
|
*Subacute dyspnea occurs within hours or days.
|
|
†Most patients should have pulse oximetry and, unless symptoms are clearly a mild exacerbation of known chronic disease, chest x-ray.
|
|
CAD = coronary artery disease.
|
|
|
Table 4
|
PrintOpen table in new window  |
 |  |  |
| Some Causes of Chronic* Dyspnea |
|
Cause
|
Suggestive Findings
|
Diagnostic Approach†
|
|
Pulmonary causes
|
|
Obstructive lung disease
|
Extensive smoking history, barrel chest, and poor air entry and exit
|
Chest x-ray
Pulmonary function testing (at initial evaluation)
|
|
Restrictive lung disease
|
Progressive dyspnea in patients with known occupational exposure or neurologic condition
|
Chest x-ray
Pulmonary function testing (at initial evaluation)
|
|
Interstitial lung disease
|
Fine crackles, frequently accompanied by dry cough
|
High-resolution chest CT
|
|
Pleural effusion
|
Pleuritic chest pain, lung field that is dull to percussion and has diminished breath sounds
Sometimes history of cancer, heart failure, RA, SLE, or acute pneumonia
|
Chest x-ray
Often chest CT and thoracentesis
|
|
Cardiac causes
|
|
Heart failure
|
Crackles, S3 gallop, and signs of central or peripheral volume overload (eg, elevated neck veins, peripheral edema)
Orthopnea or paroxysmal nocturnal dyspnea
|
Auscultation
Chest x-ray
Echocardiography
|
|
Stable angina or CAD
|
Substernal chest pressure with or without radiation to the arm or jaw, often provoked by physical exertion, particularly in patients with risk factors for CAD
|
ECG
Cardiac stress testing
Sometimes cardiac catheterization
|
|
Other causes
|
|
Anemia
|
Dyspnea on exertion progressing to dyspnea at res
Normal lung examination and pulse oximetry measurement
Sometimes systolic heart murmur due to increased flow
|
CBC
|
|
Physical deconditioning
|
Dyspnea only on exertion in patients with sedentary lifestyle
|
Clinical evaluation
|
|
*Chronic dyspnea occurs within hours to years.
|
|
†Most patients should have pulse oximetry and, unless symptoms are clearly a mild exacerbation of known chronic disease, chest x-ray.
|
|
CAD = coronary artery disease; S3
= 3rd heart sound.
|
|
Evaluation
History:
History of present illness should cover the duration, temporal onset (eg, abrupt, insidious), and provoking or exacerbating factors (eg, allergen exposure, cold, exertion, supine position). Severity can be determined by assessing the activity level required to cause dyspnea (ie, dyspnea at rest is more severe than dyspnea only with climbing stairs). For patients with baseline dyspnea, the physician should note how much dyspnea has changed from the patient's usual state.
Review of systems should seek symptoms of possible causes, including chest pain or pressure (pulmonary embolism [PE], myocardial ischemia, pneumonia); dependent edema, orthopnea, and paroxysmal nocturnal dyspnea (heart failure); fever, chills, cough, and sputum production (pneumonia); black, tarry stools or heavy menses (occult bleeding possibly causing anemia); and weight loss or night sweats (cancer or chronic lung infection).
Past medical history should cover disorders known to cause dyspnea, including asthma, COPD, and heart disease, as well as risk factors for the different etiologies:
Occupational exposures (eg, gases, smoke, asbestos) should be investigated.
Physical examination:
Vital signs are reviewed for fever, tachycardia, and tachypnea.
Examination focuses on the cardiovascular and pulmonary systems.
A full lung examination is done, particularly including adequacy of air entry and exit, symmetry of breath sounds, and presence of crackles, rhonchi, stridor, and wheezing. Signs of consolidation (eg, egophony, dullness to percussion) should be sought. The cervical, supraclavicular, and inguinal areas should be inspected and palpated for lymphadenopathy.
Neck veins should be inspected for distention, and the legs and presacral area should be palpated for pitting edema (both suggesting heart failure).
Heart sounds should be auscultated with notation of any extra heart sounds, muffled heart sounds, or murmur. Testing for pulsus paradoxus (a > 12-mm Hg drop of systolic BP during inspiration) can be done by inflating a BP cuff to 20 mm Hg above the systolic pressure and then slowly deflating until the first Korotkoff sound is heard only during expiration. As the cuff is further deflated, the point at which the first Korotkoff sound is audible during both inspiration and expiration is recorded. If the difference between the first and second measurement is > 12 mm Hg, then pulsus paradoxus is present.
Conjunctiva should be examined for pallor. Rectal examination and stool guaiac testing should be done.
Red flags:
The following findings are of particular concern:
Interpretation of findings:
The history and physical examination often suggest a cause and guide further testing (see Table 2: Symptoms of Pulmonary Disorders: Some Causes of Acute* Dyspnea , Table 3: Symptoms of Pulmonary Disorders: Some Causes of Subacute* Dyspnea , and Table 4: Symptoms of Pulmonary Disorders: Some Causes of Chronic* Dyspnea ). Several findings are of note. Wheezing (see Symptoms of Pulmonary Disorders: Wheezing) suggests asthma or COPD. Stridor (see Symptoms of Pulmonary Disorders: Stridor) suggests extrathoracic airway obstruction (eg, foreign body, epiglottitis, vocal cord dysfunction). Crackles suggest left heart failure, interstitial lung disease, or, if accompanied by signs of consolidation, pneumonia.
However, the symptoms and signs of life-threatening conditions such as myocardial ischemia and PE can be nonspecific. Furthermore, the severity of symptoms is not always proportional to the severity of the cause (eg, PE in a fit, healthy person may cause only mild dyspnea). Thus, a high degree of suspicion for these common conditions is prudent. It is often appropriate to rule out these conditions before attributing dyspnea to a less serious etiology.
A clinical prediction rule (see Symptoms of Cardiovascular Disorders: Clinical Prediction Rule for Diagnosing Pulmonary Embolism ) can help estimate the risk of PE. Note that a normal O2 saturation does not exclude PE.
Hyperventilation syndrome is a diagnosis of exclusion. Because hypoxia may cause tachypnea and agitation, it is unwise to assume every rapidly breathing, anxious young person merely has hyperventilation syndrome.
Testing:
Pulse oximetry should be done in all patients, and a chest x-ray should be done as well unless symptoms are clearly caused by a mild or moderate exacerbation of a known condition. For example, patients with asthma or heart failure do not require an x-ray for each flare-up, unless clinical findings suggest another cause or an unusually severe attack. Most adults should have an ECG to detect myocardial ischemia (and serum cardiac marker testing if suspicion is high) unless myocardial ischemia can be excluded clinically.
In patients with severe or deteriorating respiratory status, ABGs should be measured to more precisely quantify hypoxemia, measure Paco2, diagnose any acid-base disorders stimulating hyperventilation, and calculate the alveolar-arterial gradient.
 Clinical Calculator
|
|
|
Patients who have no clear diagnosis after chest x-ray and ECG and are at moderate or high risk of having PE (from the clinical prediction rule—see Symptoms of Cardiovascular Disorders: Clinical Prediction Rule for Diagnosing Pulmonary Embolism ) should undergo ventilation/perfusion scanning or CT angiography. Patients who are at low risk may have d-dimer testing (to detect the presence of clot); a normal d-dimer level effectively rules out PE in a low-risk patient.
Chronic dyspnea may warrant additional tests, such as CT, pulmonary function tests, echocardiography, and bronchoscopy.
Treatment
Treatment is correction of the underlying disorder.
Hypoxemia is treated with supplemental O2 as needed to maintain SaO2
> 88% or PaO2
> 55 mm Hg because levels above these thresholds provide adequate O2 delivery to tissues. Levels below these thresholds are on the steep portion of the O2–Hb dissociation curve, in which small declines in arterial O2 tension result in large declines in Hb saturation. O2 saturation should be maintained at > 93% if myocardial or cerebral ischemia is a concern.
Morphine 0.5 to 5 mg IV helps reduce anxiety and the discomfort of dyspnea in various conditions, including MI, PE, and the dyspnea that commonly accompanies terminal illness. However, opioids can be deleterious in patients with acute airflow limitation (eg, asthma, COPD) because they suppress the ventilatory drive and worsen respiratory acidemia.
Key Points
Last full review/revision July 2012 by Noah Lechtzin, MD, MHS
Content last modified November 2012
|  |
|